Global Smoking Cessation Drugs Market 2016-2020 - Product Image

Global Smoking Cessation Drugs Market 2016-2020

  • ID: 3704568
  • Report
  • Region: Global
  • 74 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • 22nd Century Group
  • Ballantyne Brands
  • GlaxoSmithKline
  • NAL Pharmaceuticals
  • Revolymer
  • The Harvard Drug Group
  • MORE
About Smoking Cessation Products

Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking. The analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

- GlaxoSmithKline
- Imperial Tobacco
- NJOY
- Pfizer
- Reynolds American

Other prominent vendors

- 22nd Century Group
- Alkalon
- Altria Group
- Aradigm
- Arena Pharmaceuticals
- Ballantyne Brands
- British American Tobacco (BAT)
- CB Distributors
- Cytos Biotechnology
- Electronics Cigarettes International Group (Victory Electronic Cigarettes)
- Evotec
- Gamucci
- Japan Tobacco
- Johnson & Johnson
- LOGIC Technology
- NAL Pharmaceuticals
- Nicotek
- Novartis
- Revolymer
- RR Chemicals
- Selecta Biosciences
- Target
- The Harvard Drug Group
- Vapor
- VMR Products
- Walgreens
- Wal-Mart
- White Cloud

Market drivers

- High awareness of risks associated with tobacco use

Market challenges

- Relapse after treatment

Market trends

- Ban on tobacco advertisements

Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 22nd Century Group
  • Ballantyne Brands
  • GlaxoSmithKline
  • NAL Pharmaceuticals
  • Revolymer
  • The Harvard Drug Group
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: World cigarette statistics: Per capita consumption per year

PART 06: Epidemiology
  • US
PART 07: Health implications of smoking
  • Risk of tobacco smoke on non-smokers
PART 08: Regulations on tobacco use
  • Impact of smoking bans on businesses
  • Economic benefits to individuals
PART 09: Pipeline analysis
  • NAL2762
  • X-22
  • APD356
  • GSK598809
  • SEL-068
  • ARD-1600
PART 10: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 11: Market segmentation by type
  • Global smoking cessation drugs market
  • Global NRTs market
  • Global e-cigarette market
PART 12: Market segmentation by availability
  • Prescription products
  • OTC products
PART 13: Geographical segmentation
  • Global smoking cessation products market by geography 2015-2020
  • Smoking cessation products market in Americas
  • Smoking cessation products market in EMEA
  • Smoking cessation products market in APAC
PART 14: Market drivers
  • Increase in number of smokers
  • Increase in teenage smoking
  • Significant number of public awareness programs
  • High awareness of risks associated with tobacco use
PART 15: Impact of drivers

PART 16: Market challenges
  • Side effects associated with drugs and therapies
  • Relapse after treatment
  • Weak R&D on drugs
PART 17: Impact of drivers and challenges

PART 18: Market trends
  • Increase in use of e-cigarettes
  • Increased innovation in smoking cessation products
  • Ban on tobacco advertisements
  • Increased pictorial warnings on cigarette packages
PART 19: Vendor landscape
  • Competitive scenario
  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American
  • Other prominent vendors
PART 20: Appendix
  • List of abbreviations
PART 21: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Common health effects caused by smoking
Exhibit 03: Smoking cessation products: Pipeline portfolio
Exhibit 04: Discontinued projects
Exhibit 05: Global smoking cessation products market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Global smoking cessation products market by type
Exhibit 08: Global smoking cessation products market by type 2015
Exhibit 09: Global smoking cessation drugs market 2015-2020 ($ billions)
Exhibit 10: Global NRTs market 2015-2020 ($ billions)
Exhibit 11: Global NRTs market by product 2015
Exhibit 12: Global nicotine patch market 2015-2020 ($ billions)
Exhibit 13: Nicotine patch market by geographical region 2015
Exhibit 14: Global nicotine gum market 2015-2020 ($ billions)
Exhibit 15: Nicotine gum market by geographical region 2015
Exhibit 16: Global e-cigarette market 2015-2020 ($ billions)
Exhibit 17: Global e-cigarette market: Product life cycle analysis 2015
Exhibit 18: E-cigarette market by geographical region 2015
Exhibit 19: Global smoking cessation products market by availability
Exhibit 20: Global smoking cessation products market by geography 2015
Exhibit 21: Global smoking cessation products market by geography 2020
Exhibit 22: Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
Exhibit 23: Smoking cessation products market in Americas 2015-2020 ($ billions)
Exhibit 24: Smoking cessation products market in EMEA 2015-2020 ($ billions)
Exhibit 25: Smoking cessation products market in APAC 2015-2020 ($ billions)
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Implementation of picture warnings in various countries
Exhibit 29: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 30: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 32: GlaxoSmithKline: Key takeaways
Exhibit 33: Imperial Tobacco: Business segmentation by revenue 2014
Exhibit 34: Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: Imperial Tobacco: Key takeaways
Exhibit 36: NJOY: Product categories
Exhibit 37: NJOY: Key takeaways
Exhibit 38: Pfizer: Business segmentation by revenue 2014
Exhibit 39: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 40: Pfizer: Geographical segmentation by revenue 2014
Exhibit 41: Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
Exhibit 42: Pfizer: Key takeaways
Exhibit 43: Reynolds American: Business segmentation by revenue 2014
Exhibit 44: Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 45: Reynolds American: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 22nd Century Group
  • Ballantyne Brands
  • GlaxoSmithKline
  • NAL Pharmaceuticals
  • Revolymer
  • The Harvard Drug Group
  • MORE
New Report Released: - Global Smoking Cessation Products Market 2016-2020

The author of the report recognizes the following companies as the key players in the global smoking cessation products market: GlaxoSmithKline, Imperial Tobacco, NJOY, Pfizer, and Reynolds American.

Other Prominent Vendors in the market are: 22nd Century Group, Alkalon, Altria Group, Aradigm, Arena Pharmaceuticals, Ballantyne Brands, British American Tobacco (BAT), CB Distributors, Cytos Biotechnology, Electronics Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, and White Cloud.

Commenting on the report, an analyst from the research team said: “A ban on tobacco advertisements around the world has had a positive effect on consumers. The report showed a decline of at least 16% in tobacco consumption compared to the pre-ban days. However, only 29 countries, which constitute 12% of the world's population, have banned these advertisements. Globally, one-third of countries have imposed a minimal restriction on tobacco advertisements and campaigns. It is estimated that around 78% of youngsters aged 13-15 years are exposed to advertisement or promotions for tobacco, leading them to experiment with the product.”

According to the report, more people are becoming aware of the risks associated with tobacco use. Around six million users of tobacco die every year and this number is set to increase to eight million by 2030. Cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are also caused due to tobacco use. Tobacco smoke consists of over 4,000 chemical compounds, with about 69 chemicals that are potentially known to cause cancer. These chemicals harm not only smokers, but also second-hand smokers who inhale the smoke in public spaces. Another area where the harmful effects of tobacco are witnessed are in tobacco farming, where young children from underprivileged families are often employed.

Further, the report states that the side effects associated with drugs and therapies may hinder market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- GlaxoSmithKline
- Imperial Tobacco
- NJOY
- Pfizer
- Reynolds American
- 22nd Century Group
- Alkalon
- Altria Group
- Aradigm
- Arena Pharmaceuticals
- Ballantyne Brands
- British American Tobacco (BAT)
- CB Distributors
- Cytos Biotechnology
- Electronics Cigarettes International Group (Victory Electronic Cigarettes)
- Evotec
- Gamucci
- Japan Tobacco
- Johnson & Johnson
- LOGIC Technology
- NAL Pharmaceuticals
- Nicotek
- Novartis
- Revolymer
- RR Chemicals
- Selecta Biosciences
- Target
- The Harvard Drug Group
- Vapor
- VMR Products
- Walgreens
- Wal-Mart
- White Cloud
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll